The short answer
Melatonin may add to fentanyl-related sedation, but surgical trials have not shown a uniform effect. Their monitored anesthesia regimens do not establish the safety of taking melatonin with a fentanyl patch at home.
What this answer covers
Oral melatonin with specific timing and dose; not transdermal melatonin or all prolonged-release preparations.
- Supplement or preparation
- Melatonin
- Medication ingredient
- fentanyl
One trial found more early sedation
A prostatectomy trial found greater early postoperative sedation and longer recovery after melatonin, alongside lower fentanyl use. Other anesthetics and postoperative tramadol also contributed to the regimen, so the effect cannot be attributed solely to fentanyl.
Another trial found no sedation difference
A thyroidectomy trial found no significant difference in measured sedation or fentanyl requirement after melatonin. It used different timing and multiple anesthetic medicines; this null finding deserves consideration rather than a claim of inevitable additive sedation.
A patch is a different exposure
Fentanyl patches provide prolonged opioid exposure and are restricted to opioid-tolerant patients. These surgical studies do not establish an appropriate melatonin dose or safe timing gap for patch users.
Discuss the combination before use
Tell the prescriber or anesthesia team about melatonin, including its dose and release form. Avoid driving while impaired. Slow or difficult breathing or unusual difficulty waking requires emergency help.
Evidence and practical considerations
Side effects & toxicity
Conditional sedation precaution with mixed direct co-exposure surgical findings: increased early sedation/recovery in one study, null sedation and fentanyl requirement in another. No isolated interaction magnitude or patch safety established.
- Exact scope
- Oral melatonin with specific timing and dose; not transdermal melatonin or all prolonged-release preparations. with Fentanyl4337 IN; human IV/IM citrate or transdermal product with opioid-tolerance and route boundaries.
- Medication form and route
- intravenous medication; intramuscular medication; transdermal medication; oral supplement
What remains uncertain
- No unmeasured pair incidence, blanket class transfer or arbitrary spacing interval.
Factors that may matter: Preparation; Dose; Other medicines; Organ function.
Read the supporting source summaries
Source 1: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People prescribed fentanyl
Opioid respiratory depression/CNS-depressant warnings and serotonin-syndrome precautions with serotonergic drugs.
How this applies: Exact fentanyl RxCUI 4337 IN, with stated salt/formulation/route bridge.
Not transdermal or transmucosal dosing; no supplement-specific event rate.
Source 2: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People prescribed fentanyl
CNS-depressant and serotonergic interaction warnings; heat and formulation-specific exposure risks.
How this applies: Exact fentanyl RxCUI 4337 IN, with stated salt/formulation/route bridge.
Not appropriate for opioid-naive patients or acute postoperative pain; surgical IV studies cannot define patch co-use safety.
Source 3: federal supplement safety guidance
nccih.nih.gov · Source check Sep 10, 2026
Population: Users of the specified supplement.
Daytime drowsiness can occur; people with epilepsy need medical supervision when using melatonin.
How this applies: Original source interpreted for fentanyl only within the stated preparation and endpoint limits.
Not a direct fentanyl combination trial; original preparation, dose and endpoint limits apply. No exact-pair adverse-event rate or protective spacing established.
Source 4: original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 52 surgical patients.
Higher early postoperative sedation and longer extubation/recovery; lower intraoperative fentanyl use.
How this applies: Multiple anesthetics and postoperative analgesia; cannot isolate fentanyl interaction or apply to chronic patches.
Multiple anesthetics and postoperative analgesia; cannot isolate fentanyl interaction or apply to chronic patches.
Source 5: original human study
pmc.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 50 surgical patients.
No significant difference in fentanyl requirement or measured sedation before induction and10/30minutes after extubation.
How this applies: Different operation and timing from the other trial; monitored multi-drug anesthesia, not proof of chronic patch safety.
Different operation and timing from the other trial; monitored multi-drug anesthesia, not proof of chronic patch safety.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Prepared exact fentanyl article with formulation-specific evidence and uncertainty. | |
| Research summary published |
Article revision: e5aa87d1c69c7e38
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.